Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL550002 | 1.00 | LMNA (0.53) | LMNAALDH1A1THRBTDP1TSHR | |
| Glycerin SCHEMBL19453124 | 0.97 | LMNA (0.50) | LMNAALDH1A1THRBTDP1 | |
| Glycerin SCHEMBL4330923 | 0.94 | LMNA (0.60) | LMNAALDH1A1THRBTDP1TSHR | |
| Glycerin SCHEMBL343633 | 0.94 | — | — | |
| Glycerin SCHEMBL9770227 | 0.94 | LMNA (0.60) | LMNAALDH1A1THRBTDP1TSHR | |
| Glycerin SCHEMBL13279055 | 0.94 | LMNA (0.60) | LMNAALDH1A1THRBTDP1TSHR | |
| Glycerin SCHEMBL9770368 | 0.94 | LMNA (0.60) | LMNAALDH1A1THRBTDP1TSHR | |
| Glycerin SCHEMBL10475823 | 0.94 | LMNA (0.60) | LMNAALDH1A1THRBTDP1TSHR | |
| Glycerin SCHEMBL2674761 | 0.94 | LMNA (0.60) | LMNAALDH1A1THRBTDP1TSHR | |
| Glycerin SCHEMBL29283590 | 0.91 | LMNA (0.56) | LMNAALDH1A1THRBTDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11337453-B2 | Liquid aerosol formulation of an electronic smoking article | ALTRIA CLIENT SERVICES LLC (US) | 2022-05-24 | — | — | US | claimed |
| US-11141387-B2 | Memantine-containing transdermally absorbable liquid | MEDRX CO., LTD. (JP) | 2021-10-12 | — | — | US | claimed |
| US-20200245678-A1 | LIQUID AEROSOL FORMULATION OF AN ELECTRONIC SMOKING ARTICLE | ALTRIA CLIENT SERVICES LLC (US) | 2020-08-06 | — | — | US | claimed |
| US-10660365-B2 | Liquid aerosol formulation of an electronic smoking article | ALTRIA CLIENT SERVICES LLC (US) | 2020-05-26 | — | — | US | claimed |
| US-20240016198-A1 | WATER-BASED ELECTRONIC CIGARETTE LIQUID | CHINA TOBACCO HUNAN INDUSTRIAL CO., LTD. (CN) | 2024-01-18 | — | — | US | disclosed |
| WO-2023187868-A1 | HIGH-DENSITY TOBACCO MOLDING | 日本たばこ産業株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023187871-A1 | HIGH-DENSITY TOBACCO MOLDING | 日本たばこ産業株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023052995-A1 | COMPOSITIONS WITH HIGH UREA CONTENT AND METHODS FOR BOOSTING ACTIVES | L'OREAL (FR) | 2023-04-06 | — | — | WO | disclosed |
| US-20230108443-A1 | COSMETIC SKIN CONDITIONING COMPOSITION WITH HIGH UREA CONTENT | L'OREAL (FR) | 2023-04-06 | — | — | US | disclosed |
| EP-3840596-B1 | COMPOSITION | ZANOPRIMA LIFESCIENCES LTD (GB) | 2023-02-08 | — | — | EP | disclosed |
| US-20230030621-A1 | IMPROVED STABILITY INSECTICIDAL COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | BASF SE (DE) | 2023-02-02 | — | — | US | disclosed |
| WO-2023008063-A1 | LIQUID FOR ELECTRONIC CIGARETTES, METHOD FOR MANUFACTURING LIQUID FOR ELECTRONIC CIGARETTES, CARTLIDGE FOR ELECTRONIC CIGARETTE AND ELECTRONIC CIGARETTE | 株式会社北の達人コーポレーション | 2023-02-02 | — | — | WO | disclosed |
| US-6071495-A | TEMPERATURE ACTIVATED; PARTICULARLY USEFUL, FOR EXAMPLE, IN ULTRASONIC IMAGING APPLICATIONS AND IN THERAPEUTIC DRUG DELIVERY SYSTEMS. | IMARX PHARMACEUTICAL CORP. (US) | 2000-06-06 | — | — | US | disclosed |
| EP-0959908-A1 | NOVEL TARGETED CONTRAST AGENTS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-12-01 | — | — | EP | disclosed |
| WO-1999013919-A1 | NOVEL TARGETED CONTRAST AGENTS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-03-25 | — | — | WO | disclosed |
| US-5853752-A | Methods of preparing gas and gaseous precursor-filled microspheres | IMARX PHARMACEUTICAL CORP. (US) | 1998-12-29 | — | — | US | disclosed |
| EP-0712293-A4 | METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES | UNGER EVAN C (US) | 1998-05-06 | — | — | EP | disclosed |
| US-5585112-A | TEMPERATURE-ACTIVATED FLUORINE-CONTAINING GAS; USEFUL IN ULTRASONIC IMAGING AND DRUG DELIVERY SYSTEMS; FDA ORANGE BOOK LISTED PATENT FOR PERFLUTREN | IMARX PHARMACEUTICAL CORP. (US) | 1996-12-17 | — | — | US | disclosed |
| EP-0712293-A1 | METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES | UNGER, Evan C (US) | 1996-05-22 | — | — | EP | disclosed |
| WO-1994028780-A2 | METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES | UNGER EVAN C (US) | 1994-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230108443-A1 | COSMETIC SKIN CONDITIONING COMPOSITION WITH HIGH UREA CONTENT | CUTA, SLC14A1, UTS2R | LMNA 3653/4885ALDH1A1 871/4885THRB 3137/4885 |
| US-20230030621-A1 | IMPROVED STABILITY INSECTICIDAL COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | ACHE, DDT, BCHE | LMNA 2671/4885ALDH1A1 2462/4885THRB 4873/4885 |
| US-11141387-B2 | Memantine-containing transdermally absorbable liquid | PHOSPHO1, TRPM7, TRPM8 | LMNA 813/4885ALDH1A1 4195/4885THRB 2579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.